Brain, Vol. 122, No. 8, 1589-1595,
August 1999
© 1999 Oxford University Press
Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis
1 Departments of Neurology, 2 Pathology and 3 Laboratory of Pediatrics and Neurology, University Hospital Nijmegen, 4 Department of Diagnostic Radiology, Free University Hospital, 5 Department of Neurology, Academic Medical Center and 6 Department of Neurology, University Hospital, Utrecht, The Netherlands
Correspondence to:
A. Verrips, MD, Department of Neurology, University Hospital Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands E-mail: A.Verrips{at}czzoneu.azn.nl
We describe seven Dutch patients from six families with a slowly progressive, mainly spinal cord syndrome that remained for many years the sole expression of cerebrotendinous xanthomatosis (CTX). MRI demonstrated white matter abnormalities in the lateral and dorsal columns of the spinal cord. Post-mortem examination of one of the patients showed extensive myelin loss in these columns. An array of genotypes was found in these patients. We conclude that `spinal xanthomatosis' is a clinical and radiological separate entity of CTX that should be included in the differential diagnosis of `chronic myelopathy'.
cerebrotendinous xanthomatosis; myelopathy; MRI; pathology
CDCA = chenodeoxycholic acid; CTX = cerebrotendinous xanthomatosis; CYP 27 = sterol 27-hydroxylase; LFB-HE = luxol fast blue and haematoxylin and eosin; MNF = monoclonal anti-neurofilament antibody; SSCP = single strand conformation polymorphism
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F. Barkhof and R. C. McKinstry Quantifying spinal cord demyelination with magnetic transfer imaging Neurology, May 24, 2005; 64(10): 1677 - 1678. [Full Text] [PDF] |
||||
![]() |
A. Federico and M. T. Dotti Cerebrotendinous Xanthomatosis: Clinical Manifestations, Diagnostic Criteria, Pathogenesis, and Therapy J Child Neurol, September 1, 2003; 18(9): 633 - 638. [Abstract] [PDF] |
||||
![]() |
M.-H. Lee, S. Hazard, J. D. Carpten, S. Yi, J. Cohen, G. T. Gerhardt, G. Salen, and S. B. Patel Fine-mapping, mutation analyses, and structural mapping of cerebrotendinous xanthomatosis in U.S. pedigrees J. Lipid Res., February 1, 2001; 42(2): 159 - 169. [Abstract] [Full Text] |
||||
![]() |
N. De Stefano, M. T. Dotti, M. Mortilla, and A. Federico Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis Brain, January 1, 2001; 124(1): 121 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Barkhof, A. Verrips, P. Wesseling, M. S. van der Knaap, B. G. M. van Engelen, F. J. M. Gabreëls, A. Keyser, R. A. Wevers, and J. Valk Cerebrotendinous Xanthomatosis: The Spectrum of Imaging Findings and the Correlation with Neuropathologic Findings Radiology, December 1, 2000; 217(3): 869 - 876. [Abstract] [Full Text] |
||||
![]() |
A. Verrips, L. H. Hoefsloot, G. C. H. Steenbergen, J. P. Theelen, R. A. Wevers, F. J. M. Gabreels, B. G. M. van Engelen, and L. P. W. J. van den Heuvel Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis Brain, May 1, 2000; 123(5): 908 - 919. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Verrips, B. G. M. van Engelen, R. A. Wevers, B. M. van Geel, J. R. M. Cruysberg, L. P. W. J. van den Heuvel, A. Keyser, and F. J. M. Gabreels Presence of Diarrhea and Absence of Tendon Xanthomas in Patients With Cerebrotendinous Xanthomatosis Arch Neurol, April 1, 2000; 57(4): 520 - 524. [Abstract] [Full Text] [PDF] |
||||





